Telix Pharmaceuticals Ltd ASX:TLX:

  • FDA ALIGNMENT TO ADVANCE PROSTACT GLOBAL PHASE 3 TRIAL

  • FDA AND TELIX ALIGN TO ADVANCE PROSTACT GLOBAL PHASE 3 PART 2 IN U.S.

  • FDA CONFIRMS PART 1 SAFETY DATA SUFFICIENT FOR PART 2 PROGRESSION IN U.S.

  • INITIATION OF PART 2 IN U.S. SUBJECT TO FDA IND AMENDMENT REVIEW